Company profile

Zealand Pharma

Peptide therapeutics

ZEAL · NASDAQ · Denmark

Public Market Listing

ZEALNASDAQ

NASDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for Zealand Pharma are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(5 total)
5Total Assets
0Approved
2Phase 3 / Filed
3Phase 1–2 / Early
3Diseases
Quick filter:
Showing 5 of 5 assets
Target & Modality
dasiglucagon(Zegalogue)No recent activity
Phase 3
Glucagon receptor (agonist)Peptide
Indication not yet linked
survodutide
Phase 3
GLP-1/glucagon receptor (dual)Peptide
ObesityType 2 DiabetesMASH / NASH
dapiglutide
Phase 2
GLP-1 receptorPeptide
Obesity
petrelintide
Phase 2
Amylin receptor · Amylin/calcitonin receptor (dual)Peptide
Obesity
ZP6590
Phase 1
GIP receptorPeptide
Obesity

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.